STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLBT
  4. [Form 4] Cellebrite DI Ltd. Insider Trading Activity

Cellebrite (CLBT) CMO disposes 230 RSU-related shares, retains 141,802

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cellebrite DI Ltd. executive David Nicholas Gee, Chief Marketing Officer, reported a sale of 230 ordinary shares of Cellebrite on August 12, 2026. The shares relate to restricted stock units granted on February 11, 2025, and the disposition is associated with the reporting person's tax obligations upon vesting of those RSUs. The weighted average sale price was $16.0678 per share, from multiple trades between $16.0086 and $16.08. Following this transaction, Gee directly holds 141,802 ordinary shares of Cellebrite.

Positive

  • None.

Negative

  • None.
Insider GEE DAVID NICHOLAS
Role Chief Marketing Officer
Sold 230 shs ($4K)
Type Security Shares Price Value
Sale Ordinary shares, par value NIS 0.00001 F1, F2 230 $16.0678 $4K
Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 141,802 shares (Direct)
Footnotes (2)
  1. F1. The shares reported as disposed herein were granted on February 11, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.0086 to $16.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares sold 230 shares Ordinary shares sold on August 12, 2026 by the CMO
Weighted average sale price $16.0678 per share Average price for 230 shares sold in multiple transactions
Sale price range $16.0086–$16.08 per share Price range of individual trades included in the reported sale
Shares held after transaction 141,802 shares Direct holdings of the CMO following the August 12, 2026 sale
RSU grant date February 11, 2025 Date the restricted stock units underlying the disposed shares were granted
restricted stock units financial
"The shares reported as disposed herein were granted ... in the form of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax obligations financial
"The disposition of shares is associated with tax obligations of the reporting person"
ordinary shares financial
"Ordinary shares, par value NIS 0.00001"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transaction did Cellebrite (CLBT) report for David Nicholas Gee?
Cellebrite reported that Chief Marketing Officer David Nicholas Gee sold 230 ordinary shares on August 12, 2026. The sale relates to RSU vesting and associated tax obligations, and was executed at a weighted average price of $16.0678 per share.

At what price were the 230 Cellebrite (CLBT) shares sold by the CMO?
The 230 shares were sold at a weighted average price of $16.0678 per share. According to the disclosure, the individual trades occurred in a range between $16.0086 and $16.08, with full price breakdowns available on request.

Why did Cellebrite (CLBT) CMO David Nicholas Gee dispose of 230 shares?
The filing states the disposed shares were linked to restricted stock units granted on February 11, 2025. The disposition is associated with the reporting person's tax obligations arising from the vesting of those RSUs, rather than a discretionary portfolio trade.

How many Cellebrite (CLBT) shares does the CMO hold after this transaction?
After the August 12, 2026 transaction, Chief Marketing Officer David Nicholas Gee directly holds 141,802 ordinary shares of Cellebrite. This figure reflects his post-transaction position reported in the Form 4 filing data.

Was the Cellebrite (CLBT) insider sale executed under a Rule 10b5-1 plan?
The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed for this transaction. The footnotes instead emphasize that the share disposition is tied to tax obligations related to the vesting of previously granted RSUs.

What type of security did the Cellebrite (CLBT) insider sell?
The transaction involves ordinary shares of Cellebrite, each with par value NIS 0.00001. These shares originated from restricted stock units (RSUs) granted on February 11, 2025, which vested and triggered the related tax-driven disposition.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GEE DAVID NICHOLAS
(Last)(First)(Middle)
94 SHLOMO SHMELZER ROAD
(Street)
PETAH TIKVA4970602
(City)(State)(Zip)
ISRAEL
(Country)		2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Marketing Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary shares, par value NIS 0.0000108/12/2026S(1)230D$16.0678(2)141,802D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The shares reported as disposed herein were granted on February 11, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.0086 to $16.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ David Nicholas Gee08/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR